Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ADC Therapeutics
Pharma
Patient deaths raise questions about ADC's cancer drug Zynlonta
Three times as many deaths in the study arm vs. the control arm in a trial of ADC's Zynlonta have raised questions about the antibody-drug conjugate.
Kevin Dunleavy
Jun 4, 2026 11:38am
CDMO Axplora to pump $60M into Italian complex API plant
Mar 19, 2026 8:50am
Fierce Biotech
ADC Therapeutics shutters UK R&D site, lays off 30% of staff
Jun 12, 2025 3:00pm
MilliporeSigma's production push rolls with $76M ADC investment
Oct 29, 2024 10:33am
Piramal to pump $80M into expansion of Kentucky injectables site
Oct 1, 2024 8:12am
ADC touts early Zynlonta results in marginal zone lymphoma
May 6, 2024 4:19pm
Fierce Biotech
Fierce Biotech
Fierce Biotech
Fierce Biotech
